Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001520138-21-000548
Filing Date
2021-09-16
Accepted
2021-09-16 12:47:30
Documents
2
Period of Report
2021-08-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3973
2 EX-24 exhibit_24.htm EX-24 6471
  Complete submission text file 0001520138-21-000548.txt   11901
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOVIE, INC 2120 COLORADO AVENUE, SUITE 230 SANTA MONICA CA 90404
Business Address
KIM JOANNE WENDY (Reporting) CIK: 0001771317 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39015 | Film No.: 211257435